{"id":"W4405545882","doi":"10.1186/s42358-024-00402-x","title":"Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis","year":2024,"lang":"en","type":"article","venue":"Advances in Rheumatology","topic":"Spondyloarthritis Studies and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Pfizer (Canada)","funders":"Pfizer","keywords":"Tofacitinib; Medicine; Ankylosing spondylitis; Internal medicine; Adverse effect; Placebo; Rheumatoid arthritis; Janus kinase inhibitor; Randomized controlled trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.07123876,0.00175517,0.004348144,0.003723933,0.0005946562,0.003460933,0.001046907,0.001396688,0.004569615],"category_scores_gemma":[0.07503177,0.0008297909,0.01344861,0.003903881,0.0005312435,0.001605284,0.001769745,0.00172501,0.0004477113],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001802325,"about_ca_system_score_gemma":0.004735295,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001027475,"about_ca_topic_score_gemma":0.002912213,"domain_scores_codex":[0.9251415,0.048375,0.009664564,0.004642164,0.01089955,0.001277367],"domain_scores_gemma":[0.9425359,0.0210766,0.02172114,0.004207974,0.009273193,0.001185148],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"meta_analysis","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.1661132,0.001410251,0.1047316,0.03239461,0.4077356,0.0002479049,0.0004162342,0.0044285,0.008184909,0.001239441,0.009936038,0.2631617],"study_design_scores_gemma":[0.1117166,0.05476902,0.3492821,0.008781796,0.4070421,0.00125846,0.0003199762,0.006378677,0.009837325,0.004172873,0.0461126,0.0003283515],"study_design_candidate":"meta_analysis","study_design_consensus":"meta_analysis","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.490868,0.3490387,0.05146613,0.005384491,0.001057177,0.03039425,0.05426116,0.001051064,0.01647904],"genre_scores_gemma":[0.9070466,0.02636162,0.02629719,0.002514775,0.0007890215,0.01205247,0.02334422,0.0002031919,0.001390994],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.07123876,"threshold_uncertainty_score":0.3767511,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01489621451102865,"score_gpt":0.3301643968544449,"score_spread":0.3152681823434163,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}